Mizuho Raises UnitedHealth Group (NYSE:UNH) Price Target to $460.00

UnitedHealth Group (NYSE:UNH) had its price target boosted by stock analysts at Mizuho from $440.00 to $460.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “outperform” rating on the healthcare conglomerate’s stock. Mizuho’s price objective would suggest a potential upside of 13.88% from the stock’s current price.

Several other analysts have also recently issued reports on UNH. Wells Fargo & Company increased their price objective on UnitedHealth Group from $370.00 to $397.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research note on Monday, April 20th. Bank of America raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price objective for the company from $420.00 to $450.00 in a research report on Thursday. Finally, UBS Group boosted their target price on shares of UnitedHealth Group from $410.00 to $460.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $407.17.

UnitedHealth Group Stock Up 1.1%

Shares of NYSE UNH traded up $4.46 during mid-day trading on Monday, hitting $403.93. 2,978,085 shares of the stock traded hands, compared to its average volume of 8,944,235. The company has a market cap of $366.83 billion, a price-to-earnings ratio of 30.50, a PEG ratio of 1.61 and a beta of 0.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The stock has a fifty day moving average price of $348.12 and a 200-day moving average price of $323.61. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $405.72.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts anticipate that UnitedHealth Group will post 18.32 EPS for the current year.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.28% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently made changes to their positions in the business. Sarver Vrooman Wealth Advisors purchased a new position in UnitedHealth Group during the 4th quarter worth $25,000. Beacon Financial Strategies CORP acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $26,000. Anfield Capital Management LLC grew its holdings in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $27,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.